Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXps Pensions Regulatory News (XPS)

Share Price Information for Xps Pensions (XPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.00
Bid: 230.00
Ask: 233.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.304%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 231.00
XPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

11 Jan 2018 08:03

RNS Number : 5932B
Xafinity PLC
11 January 2018
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT, WHICH DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT, IS NOT AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES, AND NEITHER THIS ANNOUNCEMENT NOR ANYTHING HEREIN FORMS THE BASIS FOR ANY CONTRACT OR COMMITMENT WHATSOEVER.

 

11 January 2018

 

Xafinity plc

 

Completion of Acquisition

 

 

Xafinity plc ("Xafinity" or the "Company") (ticker: XAF) is pleased to announce that its acquisition of Punter Southall Group Limited's actuarial consulting, pensions administration and investment consulting businesses, previously announced on 7 December 2017, has completed.

 

Admission of the 25,766,871 Completion Shares issued in connection with the Acquisition occurred at 8.00 a.m. today (11 January 2017). The Completion Shares have been admitted to the premium listing segment of the Official List and to trading on London Stock Exchange's Main Market.

 

The Company is also pleased to confirm that, as previously announced, with effect from Completion (which took place today), John Batting and Jonathan Punter have each been appointed to the board of directors of the Company. The information required by LR 9.6.13R with respect to the new directors was set out in paragraph 7 of Part 22 (Additional Information) of the class 1 circular and prospectus dated 7 December 2017 that was published by Xafinity on 8 December 2017 (the "Prospectus").

 

The issued share capital of the Company following Admission of the Completion Shares is 203,839,585 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of votes exercisable on a poll is 203,839,585. This figure may be used by Shareholders as the denominator for the calculations by which they will determine whether they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Unless otherwise stated, capitalised terms used but not defined in this announcement have the same meanings as set out in the Prospectus.

 

For further information please contact:

 

Xafinity plc

Paul Cuff, Co-CEO

+44 (0) 118 918 5110

Camarco

Ed Gascoigne-Pees

Nick Hennis

+44 (0) 20 3757 4980

 

Notes to Editors

Xafinity is a UK specialist in pensions actuarial, investment consulting and administration, providing a wide range of services to over 1,000 pension scheme clients. The Company combines expertise, insight and technology to address the needs of both pension trustees and sponsoring companies. The Xafinity Group has roughly 900 employees, of which approximately 90 per cent are client facing, with 15 offices providing the Company with access to staff, expertise and clients across the UK.

IMPORTANT NOTICE

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document.

This announcement does not constitute or form part of any offer or invitation to purchase, or otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security in the capital of the Company in any jurisdiction.

The information contained in this announcement is not for release, publication or distribution to persons in the United States, Australia, Canada, Japan or the Republic of South Africa or in any jurisdiction where to do so would breach any applicable law. The New Ordinary Shares have not been and will not be registered under the securities laws of such jurisdictions and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an exemption from and in compliance with any applicable securities laws. No public offer of the New Ordinary Shares is being made by virtue of this announcement in or into the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction outside the United Kingdom in which such offer would be unlawful. No action has been or will be taken by the Company, the Directors, or any other person to permit a public offering or distribution of this announcement or any other offering or publicity materials or the New Ordinary Shares in any jurisdiction where action for that purpose may be required, other than in the United Kingdom.

THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT, OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION AND MAY NOT BE OFFERED, SOLD, RESOLD, TRANSFERRED OR DELIVERED EXCEPT (I) OUTSIDE THE UNITED STATES IN "OFFSHORE TRANSACTIONS" AS DEFINED IN AND IN RELIANCE ON REGULATION S; OR (II) WITHIN THE UNITED STATES TO A LIMITED NUMBER OF "QUALIFIED INSTITUTIONAL BUYERS" AS DEFINED IN RULE 144A UNDER THE US SECURITIES ACT PURSUANT TO AN EXEMPTION FROM OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT. THERE WILL BE NO PUBLIC OFFER OF SECURITIES IN THE UNITED STATES.

This announcement has been issued by, and is the sole responsibility of, the Company.

This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGMGMMRMMGRZG
Date   Source Headline
20th Mar 202410:41 amRNSStandard form for notification of major holdings
19th Mar 20241:32 pmRNSHolding(s) in Company
7th Mar 20243:54 pmRNSResults of General Meeting held on 7 March 2024
6th Mar 20242:10 pmRNSHolding(s) in Company
6th Mar 202410:15 amRNSHolding(s) in Company
23rd Feb 20247:22 amRNSListing Rule 9.6.14(2) Disclosure
22nd Feb 202410:22 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading update and Notice of General Meeting
7th Feb 202411:14 amRNSDirector/PDMR Shareholding
18th Jan 20243:12 pmRNSBlock Listing Six Monthly Return
13th Dec 20234:49 pmRNSDirector/PDMR Shareholding
13th Dec 20233:13 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSNon-Executive Director Appointments
5th Dec 202310:28 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSInvestor Presentation
23rd Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSXPS completes the sale of NPT to SEI
13th Nov 20239:00 amRNSXPS appointed to provide services to John Lewis
23rd Oct 20233:58 pmRNSHolding(s) in Company
19th Oct 202312:12 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSPost-close trading update
13th Oct 202312:50 pmRNSNotice of Trading Update
9th Oct 20236:22 pmRNSHolding(s) in Company Replacement
9th Oct 20234:53 pmRNSHolding(s) in Company
7th Sep 20233:30 pmRNSResults of Annual General Meeting
5th Sep 20239:54 amRNSAGM Update
1st Sep 20232:13 pmRNSHolding(s) in Company
1st Sep 20232:10 pmRNSTotal Voting Rights and Share Capital
25th Aug 20233:33 pmRNSDirector/PDMR Shareholding
26th Jul 20234:01 pmRNSDirector/PDMR Shareholding
26th Jul 20237:10 amRNSChairman directorship notification
21st Jul 202311:30 amRNSInvestor Presentation
20th Jul 202310:53 amRNSDirector/PDMR Shareholding
18th Jul 20239:30 amRNSBlock listing Interim Review
17th Jul 20237:00 amRNSDirector/PDMR Shareholding
14th Jul 20234:45 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSNPT Strategic Partnership with SEI
13th Jul 20239:23 amRNSAnnual Report & Accounts 2022/23 and Notice of AGM
4th Jul 202311:20 amRNSDirector/PDMR Shareholding
26th Jun 202312:29 pmRNSHolding(s) in Company
23rd Jun 20234:01 pmRNSStatement re: press speculation
22nd Jun 20237:00 amRNSFinal Results
13th Jun 20235:01 pmRNSHolding(s) in Company
1st Jun 20233:27 pmRNSHolding(s) in Company
24th May 20237:00 amRNSCapital Markets Event & Post-close trading update
22nd Mar 20237:00 amRNSPre-close trading update
21st Feb 20237:00 amRNSNon-Executive Director Appointment
16th Feb 20232:57 pmRNSDirector/PDMR Shareholding
25th Jan 20233:28 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.